FibroGen, Inc.
USD9.07
-0.15 (-1.63%)
CEO
Thane Wettig
IPO Date
2014-11-14
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$9.10
Prev. Close
$9.22
Day Low
$9.02
Day High
$9.21
52W Low
$4.85
52W High
$21.95
Market Cap
$0.04B
Volume
0.03M
| 259 |
| $8.42 |
| 17 Nov 2025 | Wettig Thane | director, officer: CEO | P-Purchase | Acquired | 1,000 | $9.18 |
| 17 Nov 2025 | Wettig Thane | director, officer: CEO | P-Purchase | Acquired | 2,700 | $9.10 |
| 9 Sept 2025 | DeLucia David | Chief Financial Officer | F-InKind | Disposed | 51 | $7.83 |
| 9 Sept 2025 | DeLucia David | Chief Financial Officer | F-InKind | Disposed | 53 | $12.10 |
| 9 Sept 2025 | Wettig Thane | director, officer: CEO | F-InKind | Disposed | 246 | $7.83 |
| 9 Sept 2025 | Wettig Thane | director, officer: CEO | F-InKind | Disposed | 248 | $12.10 |
| 2 Jul 2025 | Schoeneck James A | director | P-Purchase | Acquired | 23,567 | $5.07 |
| 6 Jun 2025 | Ho Maykin | director | A-Award | Acquired | 120,000 | $0.31 |